Literature DB >> 18258439

A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.

Jacobus P D van Veldhoven1, Lisa C W Chang, Jacobien K von Frijtag Drabbe Künzel, Thea Mulder-Krieger, Regina Struensee-Link, Margot W Beukers, Johannes Brussee, Adriaan P IJzerman.   

Abstract

New adenosine receptor ligands were designed as hybrid structures between previously synthesized substituted dicyanopyridines and aminopyrimidines, yielding two series of cyano-substituted diphenylaminopyrimidines. We were interested in assessing the effect of this substitution pattern on both affinity and intrinsic activity, as the dicyanopyridines comprised both agonists and inverse agonists, whereas the original aminopyrimidines were exclusively inverse agonists. It was found that the new compounds were generally selective for adenosine A(1) receptors, although affinity for the adenosine A(2A) receptor was also noticed for some of the compounds. In a cAMP second messenger assay the compounds behaved as inverse agonists rather than agonists. Among the more A(1) receptor-selective compounds were 5 (LUF6048), 27 (LUF6040) and 53 (LUF6056) with K(i) values of 8.1, 1.2 and 5.7nM, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258439     DOI: 10.1016/j.bmc.2008.01.013

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Functional selectivity of adenosine A1 receptor ligands?

Authors:  Ellen V Langemeijer; Dennis Verzijl; Stefan J Dekker; Ad P Ijzerman
Journal:  Purinergic Signal       Date:  2012-09-28       Impact factor: 3.765

2.  Structure based prediction of subtype-selectivity for adenosine receptor antagonists.

Authors:  Vsevolod Katritch; Irina Kufareva; Ruben Abagyan
Journal:  Neuropharmacology       Date:  2010-07-15       Impact factor: 5.250

3.  Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.

Authors:  Vsevolod Katritch; Veli-Pekka Jaakola; J Robert Lane; Judy Lin; Adriaan P Ijzerman; Mark Yeager; Irina Kufareva; Raymond C Stevens; Ruben Abagyan
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

4.  Studies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A3 adenosine receptor.

Authors:  Barbara Cosimelli; Giovanni Greco; Sonia Laneri; Ettore Novellino; Antonia Sacchi; Simona Collina; Daniela Rossi; Sandro Cosconati; Elisabetta Barresi; Sabrina Taliani; Maria Letizia Trincavelli; Claudia Martini
Journal:  Medchemcomm       Date:  2017-11-09       Impact factor: 3.597

5.  Putative role of the adenosine A(3) receptor in the antiproliferative action of N (6)-(2-isopentenyl)adenosine.

Authors:  Clara C Blad; Jacobien K von Frijtag Drabbe Künzel; Henk de Vries; Thea Mulder-Krieger; Sara Bar-Yehuda; Pnina Fishman; Adriaan P Ijzerman
Journal:  Purinergic Signal       Date:  2011-07-01       Impact factor: 3.765

Review 6.  Non-Nucleoside Agonists of the Adenosine Receptors: An Overview.

Authors:  Diego Dal Ben; Catia Lambertucci; Michela Buccioni; Aleix Martí Navia; Gabriella Marucci; Andrea Spinaci; Rosaria Volpini
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-08

7.  An efficient three-component, one-pot synthesis of 2-alkylthio-4-amino-5-cyano-6-aryl(alkyl)pyrimidines in water.

Authors:  Qiao-Yan Li; Ze-Mei Ge; Tie-Ming Cheng; Run-Tao Li
Journal:  Mol Divers       Date:  2012-06-28       Impact factor: 2.943

8.  Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists.

Authors:  Cristina Val; Carlos Rodríguez-García; Rubén Prieto-Díaz; Abel Crespo; Jhonny Azuaje; Carlos Carbajales; Maria Majellaro; Alejandro Díaz-Holguín; José M Brea; Maria Isabel Loza; Claudia Gioé-Gallo; Marialessandra Contino; Angela Stefanachi; Xerardo García-Mera; Juan C Estévez; Hugo Gutiérrez-de-Terán; Eddy Sotelo
Journal:  J Med Chem       Date:  2022-01-22       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.